
Blador 25mg Tablet ER
Marketer
Koye Pharmaceuticals Pvt ltd
Salt Composition
Mirabegron (25mg)
Overview Blador 25mg Tablet ER
Blador 25mg Extended-Release tablets alleviate overactive bladder symptoms such as frequent urination, urinary urgency, and incontinence. This medication relaxes bladder muscles, improving urinary storage capacity. Always adhere to your physician's prescribed dosage and regimen for Blador 25mg ER. It may be taken with or without food; swallow the tablet whole—do not crush or chew. Discontinuing treatment prematurely may exacerbate symptoms; complete the prescribed course for optimal results. Potential side effects include constipation, headache, hypertension, rhinitis, urinary tract infection, tachycardia, and arthralgia. Report any persistent or bothersome side effects to your doctor immediately. Before starting treatment, disclose all current medications and any pre-existing health conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment require careful monitoring and regular check-ups as directed by their doctor.
Primary Ingredients of Blador 25mg Tablet ER
No text provided. Please provide the text you wish me to rephrase.
Uses of Blador 25mg Tablet ER
Managing symptoms associated with overactive bladder
Major Benefits of Blador 25mg Tablet ER:
Consume Blador 25mg Extended-Release tablets precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid crushing, chewing, or breaking it. This medication can be administered with or without food, however, consistency in timing is recommended for optimal results.
Common Side effects of Blador 25mg Tablet ER:
- Constipation
- Headache
- High blood pressure
- Nasal inflammation
- Urinary tract infection
- Fast heart rate
- Joint pain
How to use Blador 25mg Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the 25mg extended-release Blador tablet whole; avoid chewing, crushing, or fracturing it. While consumption with or without food is acceptable, consistent daily timing is recommended for optimal results.
How Blador 25mg Tablet ER works:
Extended-release Blador 25mg tablets function as a beta-3 adrenergic agonist. Their mechanism involves stimulating bladder beta-3 receptors, leading to detrusor muscle relaxation and a reduction in urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
Use Blador 25mg Tablet ER with alcohol only under medical supervision. Consult your physician before combining them.
PregnancyCONSULT YOUR DOCTOR
Extended-release Blador 25mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the benefits against potential risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Blador 25mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Extended-release Blador 25mg tablets typically do not impair driving ability.
KidneyCAUTION
Extended-release Blador 25mg tablets require careful administration in individuals with advanced kidney impairment. Dosage modification for Blador 25mg extended-release tablets may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should use Blador 25mg Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Blador 25mg Extended-Release tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Blador 25mg Tablet ER :
Should you forget a Blador 25mg Extended-Release Tablet, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Blador 25mg Tablet ER
| Label | Value |
|---|---|
| Chemical Classification | Anilide-based compound |
| Developing Habits | No. |
| Treatment Category | Urology |
| Behavior Class | Beta-3 agonist for bladder control |
